1. Home
  2. GKOS vs RIOT Comparison

GKOS vs RIOT Comparison

Compare GKOS & RIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$173.00

Market Cap

9.7B

Sector

Health Care

ML Signal

HOLD

Logo Riot Platforms Inc.

RIOT

Riot Platforms Inc.

HOLD

Current Price

$18.38

Market Cap

8.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
RIOT
Founded
1998
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.1B
IPO Year
2015
2002

Fundamental Metrics

Financial Performance
Metric
GKOS
RIOT
Price
$173.00
$18.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
22
Target Price
★ $198.69
$32.36
AVG Volume (30 Days)
723.3K
★ 13.1M
Earning Date
10-28-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$507,442,000.00
★ $647,435,000.00
Revenue This Year
$36.18
$4.49
Revenue Next Year
$23.04
$18.23
P/E Ratio
★ N/A
N/A
Revenue Growth
32.33
★ 71.89
52 Week Low
$73.16
$11.50
52 Week High
$191.62
$30.32

Technical Indicators

Market Signals
Indicator
GKOS
RIOT
Relative Strength Index (RSI) 56.54 36.54
Support Level $148.39 $17.71
Resistance Level $184.68 $19.07
Average True Range (ATR) 6.50 1.27
MACD 1.09 -0.55
Stochastic Oscillator 89.32 5.76

Price Performance

Historical Comparison
GKOS
RIOT

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About RIOT Riot Platforms Inc.

Riot Platforms Inc is a vertically integrated digital infrastructure company principally engaged in developing and optimizing its large-scale power assets. The Company's business centers on enhancing its electrical infrastructure and deploying it across two complementary platforms: (i) Bitcoin Mining and (ii) scalable data center solutions designed to support non-mining workloads. The company's segments include Bitcoin Mining and Engineering. The Bitcoin Mining segment generates revenue from the Bitcoin the Company earns through its Bitcoin Mining activities. The Engineering segment generates revenue through customer contracts for custom engineered electrical products. It generates the majority of its revenue from the Bitcoin Mining segment.

Share on Social Networks: